Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

3.5K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.5K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

16.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regenerative macrophages enhance stem cell-derived β cell function and engraftment.

Science advances·2026
Same author

Engineering human T cells with antigen receptors for immune regulation in autoimmune disease and transplantation.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Reproducible detection of antigen-specific T cells and Tregs via standardized and automated activation-induced marker assay workflows.

Cell reports methods·2026
Same author

Human and mouse regenerative macrophages enhance beta cell survival, function, and proliferation.

Islets·2026
Same author

Beta Integrin Expression Defines Functionally Distinct CD4<sup>+</sup> T-Cell Subsets That Are Altered in Ulcerative Colitis.

Gastro hep advances·2026
Same author

Chronic graft-versus-host disease suppressing CD56<sup>bright</sup>Perforin<sup>neg</sup> regulatory-like NK cells inhibit CD4<sup>+</sup> T cells via PD-1, LAG-3, and TRAIL.

Cytotherapy·2026

Related Experiment Video

Updated: Feb 18, 2026

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.3K

Engineered Tolerance: Tailoring Development, Function, and Antigen-Specificity of Regulatory T Cells.

Nicholas A J Dawson1,2, Jens Vent-Schmidt1, Megan K Levings2,3

  • 1Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Frontiers in Immunology
|November 23, 2017
PubMed
Summary

Regulatory T cells (Tregs) are crucial for immune suppression and are being explored for transplantation and autoimmune diseases. Engineering approaches show promise for overcoming current limitations in Treg therapies.

Keywords:
IL-2T cell receptorautoimmunitychimeric antigen receptorsimmunotherapyinflammatory bowel diseaseregulatory T cellstransplantation

More Related Videos

Generation of Induced Regulatory T Cells from Primary Human Na&#239;ve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.9K
Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

16.5K

Related Experiment Videos

Last Updated: Feb 18, 2026

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.3K
Generation of Induced Regulatory T Cells from Primary Human Na&#239;ve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.9K
Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

16.5K

Area of Science:

  • Immunology
  • Cellular Therapy
  • Biotechnology

Background:

  • Regulatory T cells (Tregs) are critical for immune tolerance.
  • Tregs are being investigated for treating autoimmunity and transplant rejection.
  • Current Treg therapies face challenges in cell isolation and expansion.

Purpose of the Study:

  • To review advanced cell and protein engineering strategies for Treg-based immunotherapies.
  • To highlight methods for improving Treg product quality and targeting.
  • To discuss the potential of engineered Tregs in clinical applications.

Main Methods:

  • Review of current literature on Treg engineering.
  • Analysis of approaches modulating IL-2 signaling and FOXP3 expression.
  • Examination of antigen-specific Treg generation using engineered receptors.

Main Results:

  • Engineering strategies offer solutions to Treg isolation and expansion limitations.
  • Modulating Treg biology can enhance their suppressive function.
  • Targeted antigen-specificity can improve Treg therapy efficacy.

Conclusions:

  • Engineered Treg therapies hold significant potential for fine-tuning immune tolerance.
  • These approaches may overcome current hurdles in Treg-based immunotherapy.
  • Further pre-clinical and clinical studies are warranted to realize therapeutic benefits.